Magnolia Research Group is a clinical research site located in Ocala, Florida, United States.
Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.
Magnolia Research Group has participated in 4 clinical trials.
Therapeutic areas: Alzheimer Disease, Diabetes Mellitus, Type 2, Arthritis, Rheumatoid.
Sponsors: Boehringer Ingelheim, Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Otsuka Pharmaceutical Development & Commercialization, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Florida · View every site in Ocala
Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Magnolia Research Group has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Magnolia Research Group has 4 clinical trials on record. Their work covers Alzheimer Disease, Diabetes Mellitus, Type 2, Arthritis, Rheumatoid.
Magnolia Research Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.